 prostat specif antigen irradi prostat carcinoma clinic signific serum prostat specif antigen primari irradi adenocarcinoma prostat uncertain between septemb decemb serial prostat specif antigen valu patient definit radiat therapi studi group patient stage stage stage stage diseas mean pre-treat prostat specif antigen level patient first post-treat prostat specif antigen level pre-treat level patient recurr prostat cancer rectum patient symptomat metastas prostat specif antigen level month detect recurr absolut valu trend prostat specif antigen patient high intermedi low risk distant metastas high intermedi low risk patient recurr diseas serial post-irradi prostat specif antigen valu use earli identif patient risk treatment failur